FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2943457897> ?p ?o ?g. }

• W2943457897 endingPage "372" @default.
• W2943457897 startingPage "366" @default.
• W2943457897 abstract "The interleukin-33/interleukin-13 pathway is involved in the immunopathology of liver fibrosis and recently characterized group 2 innate lymphoid cells (ILC2) were identified as profibrotic immune cells in the liver of mouse models. Our aim was to elucidate whether ILC2 might be present in human liver tissue and whether ILC2 contribute to liver fibrosis. To identify ILC2 in liver tissue and blood, we purified mononuclear immune cells from needle biopsies, cirrhotic explant specimen, and paired peripheral blood samples. Cell suspensions were incubated with specific markers for ILC2 and analyzed by flow cytometry. The CD69 marker was included to assess the activation level of ILC2. In addition, we determined the IL-33 plasma level. Results were correlated with the METAVIR fibrotic score of patients enrolled in this study. We detected ILC2 in a higher percentage of CD45+ cells in liver tissue than in paired peripheral blood. The number of ILC2 was significantly increased in fibrotic tissue, but only slightly increased in paired peripheral blood. A higher percentage of CD69+ ILC2 was observed in fibrotic tissue, and this increase correlates positively with aggravation of liver fibrosis measured by fibrotic METAVIR score. A higher level of plasma IL-33 was only detected in samples obtained from cirrhotic patients. Our study indicates that ILC2 are present in the human liver and are activated in tissue contributing to the immunopathology of human liver fibrosis, independently of the etiology; which might be a potential new therapeutic target." @default.
• W2943457897 created "2019-05-09" @default.
• W2943457897 creator A5011700366 @default.
• W2943457897 creator A5018972895 @default.
• W2943457897 creator A5019869361 @default.
• W2943457897 creator A5030934265 @default.
• W2943457897 creator A5033371517 @default.
• W2943457897 creator A5071170000 @default.
• W2943457897 creator A5071646464 @default.
• W2943457897 creator A5082794851 @default.
• W2943457897 creator A5090256822 @default.
• W2943457897 date "2019-03-01" @default.
• W2943457897 modified "2023-10-18" @default.
• W2943457897 title "Group 2 innate lymphoid cells exhibit progressively higher levels of activation during worsening of liver fibrosis" @default.
• W2943457897 cites W1500518582 @default.
• W2943457897 cites W1837132695 @default.
• W2943457897 cites W1877178826 @default.
• W2943457897 cites W1967715707 @default.
• W2943457897 cites W1969324457 @default.
• W2943457897 cites W1975547565 @default.
• W2943457897 cites W1978311073 @default.
• W2943457897 cites W1983357763 @default.
• W2943457897 cites W1997883939 @default.
• W2943457897 cites W2008875301 @default.
• W2943457897 cites W2010180179 @default.
• W2943457897 cites W2015053270 @default.
• W2943457897 cites W2042237784 @default.
• W2943457897 cites W2047875752 @default.
• W2943457897 cites W2050729903 @default.
• W2943457897 cites W2064346298 @default.
• W2943457897 cites W2069819211 @default.
• W2943457897 cites W2073361650 @default.
• W2943457897 cites W2106790228 @default.
• W2943457897 cites W2120394416 @default.
• W2943457897 cites W2130509509 @default.
• W2943457897 cites W2167289017 @default.
• W2943457897 cites W2229487052 @default.
• W2943457897 cites W2314023264 @default.
• W2943457897 cites W2408392972 @default.
• W2943457897 cites W2462468519 @default.
• W2943457897 cites W2557148924 @default.
• W2943457897 cites W2562858382 @default.
• W2943457897 cites W2735947195 @default.
• W2943457897 cites W2778138625 @default.
• W2943457897 cites W4319308391 @default.
• W2943457897 doi "https://doi.org/10.1016/j.aohep.2018.12.001" @default.
• W2943457897 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31053540" @default.
• W2943457897 hasPublicationYear "2019" @default.
• W2943457897 type Work @default.
• W2943457897 sameAs 2943457897 @default.
• W2943457897 citedByCount "22" @default.
• W2943457897 countsByYear W29434578972019 @default.
• W2943457897 countsByYear W29434578972020 @default.
• W2943457897 countsByYear W29434578972021 @default.
• W2943457897 countsByYear W29434578972022 @default.
• W2943457897 countsByYear W29434578972023 @default.
• W2943457897 crossrefType "journal-article" @default.
• W2943457897 hasAuthorship W2943457897A5011700366 @default.
• W2943457897 hasAuthorship W2943457897A5018972895 @default.
• W2943457897 hasAuthorship W2943457897A5019869361 @default.
• W2943457897 hasAuthorship W2943457897A5030934265 @default.
• W2943457897 hasAuthorship W2943457897A5033371517 @default.
• W2943457897 hasAuthorship W2943457897A5071170000 @default.
• W2943457897 hasAuthorship W2943457897A5071646464 @default.
• W2943457897 hasAuthorship W2943457897A5082794851 @default.
• W2943457897 hasAuthorship W2943457897A5090256822 @default.
• W2943457897 hasBestOaLocation W29434578971 @default.
• W2943457897 hasConcept C136449434 @default.
• W2943457897 hasConcept C137061746 @default.
• W2943457897 hasConcept C142724271 @default.
• W2943457897 hasConcept C202751555 @default.
• W2943457897 hasConcept C203014093 @default.
• W2943457897 hasConcept C2780559512 @default.
• W2943457897 hasConcept C47742525 @default.
• W2943457897 hasConcept C553184892 @default.
• W2943457897 hasConcept C55493867 @default.
• W2943457897 hasConcept C71924100 @default.
• W2943457897 hasConcept C86803240 @default.
• W2943457897 hasConcept C8891405 @default.
• W2943457897 hasConceptScore W2943457897C136449434 @default.
• W2943457897 hasConceptScore W2943457897C137061746 @default.
• W2943457897 hasConceptScore W2943457897C142724271 @default.
• W2943457897 hasConceptScore W2943457897C202751555 @default.
• W2943457897 hasConceptScore W2943457897C203014093 @default.
• W2943457897 hasConceptScore W2943457897C2780559512 @default.
• W2943457897 hasConceptScore W2943457897C47742525 @default.
• W2943457897 hasConceptScore W2943457897C553184892 @default.
• W2943457897 hasConceptScore W2943457897C55493867 @default.
• W2943457897 hasConceptScore W2943457897C71924100 @default.
• W2943457897 hasConceptScore W2943457897C86803240 @default.
• W2943457897 hasConceptScore W2943457897C8891405 @default.
• W2943457897 hasFunder F4320310753 @default.
• W2943457897 hasFunder F4320324143 @default.
• W2943457897 hasIssue "2" @default.
• W2943457897 hasLocation W29434578971 @default.
• W2943457897 hasLocation W29434578972 @default.
• W2943457897 hasLocation W29434578973 @default.
• W2943457897 hasOpenAccess W2943457897 @default.

• next